Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bruce N. Jacobs currently holds 227,409 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce N. Jacobs has been a net seller of KYMR stock. They have purchased $0 and sold $8.6M worth of shares.
Bruce N. Jacobs's most recent insider trade was on Sep 17, 2025, when they sold 79,220 shares at $50.00 per share.
Bruce N. Jacobs serves as Executive at Kymera Therapeutics, Inc. (KYMR). They have executed 46 insider transactions totaling $8.6M over their tenure at the company.
Bruce N. Jacobs holds the position of Executive at Kymera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Bruce N. Jacobs has shown a selling trading pattern, with $0 in total purchases and $8.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bruce N. Jacobs was on Sep 17, 2025, when they sold $4.0M worth of KYMR shares. This transaction involved 79,220 shares at $50.00 per share.
Bruce N. Jacobs currently owns 227,409 shares of Kymera Therapeutics, Inc. (KYMR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bruce N. Jacobs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bruce N. Jacobs has 46 Form 4 filings on record as an insider at Kymera Therapeutics, Inc..
Set alerts for Bruce N. Jacobs and 40,000+ other insiders.